SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout
Access

Company profile

SVA

Sinovac Biotech Ltd.
NASDAQHealth Care

Latest close: 6.47 USD · Jul 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 17, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
  2. Jul 15, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗
  3. Jun 15, 2026Periodic report · 6-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year178
SEC filings on record55415 flagged findings
Reported transactions (Form 4)0and 10 other holdings
Corporate events (8-K)0

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 554)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

554 filings on record, the oldest from Oct 26, 00.

Listing the 25 most recent filings of the 554 on record.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • 1Globe Capital LLC32.3%Sep 10, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • SAIF Partners IV L.P.15.0%Dec 15, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • Weidong Yin8.8%Jul 10, 25SCHEDULE 13D/A ↗2 earlier filings
  • Advantech Capital L.P.8.1%Jul 8, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Vivo Capital IX, LLC6.3%Jul 11, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Its sector and its market

Sinovac Biotech Ltd. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Sinovac Biotech Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →

  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →

  3. Keep the why

    Follow Sinovac Biotech Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
554 documents on file, from Oct 26, 2000 to Aug 17, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Request beta accessAll companies ↑

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.